Aegera Therapeutics
Latest round
- Series C
Last raised
- Nov 2006
Total raised
- $34M
Investors
- 8
About Aegera Therapeutics
, is based in Quebec, Canada and is a clinical-stage biotechnology company, develops targeted therapeutics for various unmet medical needs.
Who invested in Aegera Therapeutics
8 investors across 2 rounds
See all investors in Aegera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aegera Therapeutics
Who invested in Aegera Therapeutics?
Aegera Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aegera Therapeutics raised?
Aegera Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aegera Therapeutics last raise money?
Aegera Therapeutics's most recent round on record is a Series C, in Nov 2006.
What does Aegera Therapeutics do?
, is based in Quebec, Canada and is a clinical-stage biotechnology company, develops targeted therapeutics for various unmet medical needs.
Where is Aegera Therapeutics headquartered?
Aegera Therapeutics is headquartered in Montreal, Canada.
Which VCs invest in companies like Aegera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aegera Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Aegera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.